Animal models of COVID-19 hyper-inflammation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Contemporary Concise Review 2021: COVID-19 and other respiratory infections.Respirology (Carlton, Vic.) · 2022
   Review
2. De Novo-Whole Genome Assembly of the Roborovski Dwarf Hamster (Phodopus roborovskii) Genome: An Animal Model for Severe/Critical COVID-19.Genome biology and evolution · 2022
   Article
3. Hamster models of COVID-19 pneumonia reviewed: How human can they be?Veterinary pathology · 2022
   Review
4. A new mouse unilateral model of diffuse alveolar damage of the lung.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
   Article
5. Animal models and COVID-19: Mechanism and comorbidities.Respirology (Carlton, Vic.) · 2021
   Article

Corrections and comments

• Commented on by
  Animal models and COVID-19: Mechanism and comorbidities.2021
• Commented on by
  Reply.2021
• Comment on
  Animal models for COVID-19.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as